Keywords: مهارکننده های DPP-IV; Abdominal aortic aneurysm; Glucagon-like peptide-1; GLP-1; Dipeptidyl peptidase-4 inhibitors; DPP-IV inhibitors; Proglucagon-derived hormones;
مقالات ISI مهارکننده های DPP-IV (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مهارکننده های DPP-IV; DPP-IV inhibitors; GLP-1 agonists; SGLT-2 inhibitors; Diabetic nephropathy; Chronic kidney disease;
Keywords: مهارکننده های DPP-IV; AMPK; AMP-activated protein kinase; CHD; Coronary Heart Disease; CI; Confidence Interval; CV; Cardiovascular; DPP-IV inhibitors; Dipeptidyl peptidase-4 inhibitors; GLP-1 receptor agonists; Glucagon-like peptide-1 receptor agonists; HF; Heart Failure; HR;
Keywords: مهارکننده های DPP-IV; Saxagliptin (PubChem CID: 66576989); KR-62436 (PubChem CID: 11403745); Sodium nitroprusside anhydrous (PubChem CID: 11963579); l-nitroarginine methylester (PubChem CID: 39836)COX; DPP-IV inhibitors; Endothelium; Microcirculation; Oxidative stress
Keywords: مهارکننده های DPP-IV; Electrospinning; Proteins; Drug delivery; Bioactive; Biodegradable; DPP-IV inhibitors;
Dipeptidyl peptidase IV inhibitors as novel regulators of vascular disease
Keywords: مهارکننده های DPP-IV; Atherosclerosis; Oxidative stress; Perivascular adipose tissue; DPP-IV inhibitors;
In vitro evidence for gut hormone stimulation release and dipeptidyl-peptidase IV inhibitory activity of protein hydrolysate obtained from cuttlefish (Sepia officinalis) viscera
Keywords: مهارکننده های DPP-IV; Bioactive peptides; DPP-IV inhibitors; Incretin effect; GLP-1; CCK; Diabetes
Design, synthesis and biological evaluation of novel aminomethyl-piperidones based DPP-IV inhibitors
Keywords: مهارکننده های DPP-IV; Aminomethyl-piperidones; DPP-IV inhibitors; Long-acting; Selective; Antidiabetic
Synthesis and biological evaluation of all eight stereoisomers of DPP-IV inhibitor saxagliptin
Keywords: مهارکننده های DPP-IV; Saxagliptin; Stereoisomers; Synthesis; Configuration–activity relationship; DPP-IV inhibitors
Structure based virtual screening of MDPI database: Discovery of structurally diverse and novel DPP-IV inhibitors
Keywords: مهارکننده های DPP-IV; DPP-IV inhibitors; Type-2 diabetes; Glucagon-like peptide-1; Molecular Diversity Preservation International;
Decreased carotid atherosclerotic process by control of daily acute glucose fluctuations in diabetic patients treated by DPP-IV inhibitors
Keywords: مهارکننده های DPP-IV; Daily glucose variability; Atherosclerosis; DPP-IV inhibitors; Type 2 diabetes; Inflammation; Oxidative stress;
Incretin-based therapy in combination with basal insulin: A promising tactic for the treatment of type 2 diabetes
Keywords: مهارکننده های DPP-IV; Insulin; GLP-1 analogue; DPP-IV inhibitors; Type 2 diabetes mellitus; HbA1c; Weight; ReviewDiabète de type 2; Analogues du GLP-1; Inhibiteurs des DPP-IV; Insulinothérapie basale; Association; Poids; Revue générale
Long-acting peptidomimetics based DPP-IV inhibitors
Keywords: مهارکننده های DPP-IV; Peptidomimetic; DPP-IV inhibitors; Slow-binding; Selectivity; Antidiabetic; Long-acting
Addressing Cardiovascular Risk in Patients With Type 2 Diabetes: Focus on Primary Care
Keywords: مهارکننده های DPP-IV; Type 2 diabetes; Cardiovascular disease; Glycemic control; Hemoglobin A1C; GLP-1 receptor agonists; DPP-IV inhibitors;
Inhibition of multifunctional dipeptidyl peptidase-IV: Is there a risk of oncological and immunological adverse effects?
Keywords: مهارکننده های DPP-IV; Diabetes mellitus; Dipeptidyl peptidase-IV; DPP-IV inhibitors; Drug safety; Immune suppression; Cancer
Les incrétines
Keywords: مهارکننده های DPP-IV; GLP-1; Analogues du GLP-1; Inhibiteurs de la DPP-IV; Diabète de type-2GLP-1; GHLP-1 analogs; DPP-IV inhibitors; Diabetes mellitus type-2
Optimization of 1,4-diazepan-2-one containing dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes
Keywords: مهارکننده های DPP-IV; Type 2 diabetes; DPP-IV inhibitors; 1,4-Diazepan-2-one
Type 2 diabetes mellitus: epidemiology, pathophysiology, unmet needs and therapeutical perspectives
Keywords: مهارکننده های DPP-IV; DPP-IV inhibitors; Epidemiology; France; Glinides; GLP1 analogues; Metformin; Obesity; Pathogenesis; Sulfonylureas; Review; Treatment antidiabetic oral agents; Type 2 diabetes mellitusÉpidémiologie du diabète; Épidémie de diabète; Obésité; France; Physiop